A simple drug cocktail that converts cells neighboring damaged neurons into functional new neurons could potentially be used to treat stroke, Alzheimer’s disease, and brain injuries.
A team of researchers at Penn State identified a set of four, or even three, molecules that could convert glial cells—which normally provide support and insulation for neurons—into new neurons. A paper describing the approach appears online in the journal Stem Cell Reports on February 7, 2019.
“The biggest problem for brain repair is that neurons don’t regenerate after brain damage, because they don’t divide,” said Gong Chen, professor of biology and Verne M. Willaman Chair in Life Sciences at Penn State and leader of the research team. “In contrast, glial cells, which gather around damaged brain tissue, can proliferate after brain injury. I believe turning glial cells that are the neighbors of dead neurons into new neurons is the best way to restore lost neuronal functions.”
Chen’s team previously published research describing a sequence of nine small molecules that could directly convert human glial cells into neurons, but the large number of molecules and the specific sequence required for reprogramming the glial cells complicated the transition to a clinical treatment. In the current study, the team tested various numbers and combinations of molecules to identify a streamlined approach to the reprogramming of astrocytes, a type of glial cells, into neurons.
“We identified the most efficient chemical formula among the hundreds of drug combinations that we tested,” said Jiu-Chao Yin, a graduate student in biology at Pen State who identified the ideal combination of small molecules. “By using four molecules that modulate four critical signaling pathways in human astrocytes, we can efficiently turn human astrocytes—as many as 70 percent—into functional neurons.”
The resulting chemically converted neurons can survive more than seven months in a culture dish in the lab. They form robust neural networks and send chemical and electrical signals to each other, as normal neurons do inside the brain.
Using three of the small molecules instead of four also results in the conversion of astrocytes into neurons, but the conversion rate drops by about 20 percent. The team also tried using only one of the molecules, but this approach did not induce conversion.
Chen and his team had previously developed a gene therapy technology to convert astrocytes into functional neurons, but due to the excessive cost of gene therapy—which can cost a patient half a million dollars or more—the team has been pursuing more economical approaches to convert glial cells into neurons. The delivery system for gene therapies is also more complex, requiring the injection of viral particles into the human body, whereas the small molecules in the new method can be chemically synthesized and packaged into a pill.
“The most significant advantage of the new approach is that a pill containing small molecules could be distributed widely in the world, even reaching rural areas without advanced hospital systems,” said Chen. “My ultimate dream is to develop a simple drug delivery system, like a pill, that can help stroke and Alzheimer’s patients around the world to regenerate new neurons and restore their lost learning and memory capabilities.”
The researchers acknowledge that many technical issues still need to be resolved before a drug using small molecules could be created, including the specifics of drug packaging and delivery. They also plan to investigate potential side effects of this approach in future studies in order to develop the safest drug pills. Nonetheless, the research team is confident that this combination of molecules has promising implications for future drug therapies to treat individuals with neurological disorders.
“Our years of effort in discovering this simplified drug formula take us one step closer to reaching our dream,” said Chen.
The Latest on: Small molecules
via Google News
The Latest on: Small molecules
$1 million award lets UVA open new portal to submicroscopic world
on February 21, 2019 at 1:40 pm
Michael Wiener, PhD, a professor (and first-generation college grad) in UVA's Department of Molecular Physiology and Biological Physics, is seeking to create a simpler, more reliable method to determi... […]
Nanoparticles Highlight Organ Transplant Rejection Through Fluorescent Urine
on February 21, 2019 at 12:25 pm
it cleaves the bristles and releases the fluorescent molecules, which travel through the bloodstream and end up in the urine. So far, the researchers have tested the system in mice that received small ... […]
Small Molecule Targeted Cancer Therapy Market|Healthy Growth in 2019 Annual Results
on February 20, 2019 at 9:24 pm
Small molecule targeted cancer therapy is the medication that blocks the cancerous cells growth by destroying the targeted molecules which results in the growth of tumor and carcinogenesis (formation ... […]
Putting grapes in the microwave has fiery consequences thanks to ‘charged molecules’
on February 19, 2019 at 12:28 am
In fact, electromagnetic resonance led to concentrated spots where the ‘ionised’ molecules generated a ... Part of the study involved small quail eggs, which were also shown to produce hot ... […]
Small, Selective Gas Sensors
on February 18, 2019 at 9:06 am
When the reaction is complete, the product departs and the catalyst remains to enable a future reaction with new reagents. Molecules come in, they get hitched, and – here’s the key – they leave to sta... […]
New Molecules Reverse Memory Loss from Aging
on February 16, 2019 at 2:25 am
The new small molecules were invented to bind to and activate this receptor target. The idea was that they would exert a therapeutic effect by "fixing" the impairment, resulting in an improvement ... […]
Lefty or righty molecules lend a hand to material structures
on February 15, 2019 at 4:57 pm
That seems to be an operating principle for molecules that start with a basic chirality -- or ... synthetic materials that naturally assemble themselves from small building blocks. They found the left ... […]
Therapeutic Molecules Reverse Memory Loss from Depression, Aging
on February 15, 2019 at 4:36 am
As such, the team engineered new small but powerful molecules which were chemical tweaks of benzodiazepines. These therapeutic molecules were created to bind to and activate the GABA receptor ... […]
Axovant spins out new company focused on small molecules
on February 14, 2019 at 9:58 am
Axovant Sciences (AXON-1.6%) has formed a separate company called Arvelle Therapeutics that will focus on developing small molecule drugs, enabling Axovant to focus solely on gene therapies. […]
Small Molecule API Market Demand, Size, Revenue, Leading Players, Historical Analysis, Drivers and Outlook till 2027
on February 14, 2019 at 3:01 am
Most of the drugs are small molecules except larger structures such as nucleic acids and proteins and polysaccharides. Small molecule APIs are an important and highly effective component of the bio/ph... […]
via Bing News